Burning Rock Biotech Limited BNR
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -0.23% | 4.67% | 5.35% | 5.29% | -0.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.23% | 4.67% | 5.35% | 5.29% | -0.35% |
| Cost of Revenue | -10.94% | -10.94% | -9.12% | -9.09% | -13.17% |
| Gross Profit | 4.05% | 11.27% | 11.93% | 12.15% | 5.89% |
| SG&A Expenses | -22.68% | -35.53% | -44.57% | -51.88% | -41.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.86% | -29.02% | -34.08% | -40.54% | -35.29% |
| Operating Income | 71.84% | 82.96% | 79.72% | 80.68% | 65.33% |
| Income Before Tax | 74.71% | 84.17% | 72.91% | 76.14% | 60.67% |
| Income Tax Expenses | -73.25% | -73.39% | 265.74% | 217.65% | 175.52% |
| Earnings from Continuing Operations | 74.67% | 83.99% | 71.61% | 75.16% | 59.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.67% | 83.99% | 71.61% | 75.16% | 59.81% |
| EBIT | 71.84% | 82.96% | 79.72% | 80.68% | 65.33% |
| EBITDA | 81.10% | 94.78% | 87.66% | 90.99% | 75.14% |
| EPS Basic | 75.38% | 84.59% | 72.20% | 75.53% | 60.12% |
| Normalized Basic EPS | 46.12% | 78.37% | 78.33% | 80.59% | 85.01% |
| EPS Diluted | 75.38% | 84.59% | 72.20% | 75.53% | 60.12% |
| Normalized Diluted EPS | 46.12% | 78.37% | 78.33% | 80.59% | 85.01% |
| Average Basic Shares Outstanding | 2.06% | 3.91% | 3.81% | 2.93% | 1.72% |
| Average Diluted Shares Outstanding | 2.06% | 3.91% | 3.81% | 2.94% | 1.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |